(Q33845160)

English

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

scientific article

Statements

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. (English)
1474-1481

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit